The award, which is given to individuals for their commitment to the fight against AIDS and their contributions to improving HIV care in marginal populations, was announced on December 1, which is recognized globally as World AIDS Day.
Cohen was given the Hope is a Vaccine award for his dedication to providing a scientific foundation for the Treatment as Prevention concept. Cohen is principal investigator of a landmark study, HIV Prevention Trials Network (HPTN) 052, which showed that treating HIV-infected individuals with antiretrovirals early led to a 96 percent reduction in transmission to their uninfected partners.
Cohen’s primary research focus is on transmission and prevention of transmission of HIV, with emphasis on the role played by STD co-infections. Much of Cohen’s research has been conducted in resource constrained countries, particularly Malawi, South Africa, and the People’s Republic of China.
Cohen is also associate vice chancellor for global health, chief of infectious disease medicine, and director of the UNC Institute for Global Health & Infectious Diseases.
To learn more about the GAIA Vaccine Foundation and this award, visit http://gaiavaccine.org/